Drug rebates in Medicare Part D: Excess patient costs in the case of hepatitis C treatments: Running Header: Drug Rebates in Medicare Part D

Yorgos Arambadjis, Mary E Butler, Peter Huckfeldt, Stephen W Schondelmeyer

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Drug rebates in Medicare Part D: Excess patient costs in the case of hepatitis C treatments: Running Header: Drug Rebates in Medicare Part D'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds